𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

✍ Scribed by Mistry, Pramod; Lukina, Elena; Dridi, Marie-Françoise Ben; Amato, Dominick; Baris, Hagit; Dasouki, Majed; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory; Petakov, Milan; Peterschmitt, M. Judith


Book ID
122788913
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
77 KB
Volume
108
Category
Article
ISSN
1096-7192

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES